Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors

US Patent 10918712 · Granted Feb 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies for prevention and treatment of herpes simplex viral infec2025
Monoclonal antibodies for prevention and treatment of herpes simplex viral infec2025
HSV-2-delta-gD vaccines and methods for their production and use2024
HSV-2-delta-gD vaccines and methods for their production and use2024
Double auxotrophic mycobacterium and uses thereof2024
Attb cell line, transgenic cell lines derived therefrom, and methods of making t2024
Methods of using HSV-2 single cycle virus delta-gD and HSV-2 recombinant glycopr2023
Double auxotrophic Mycobacterium and uses thereof2023
Prevention and treatment of viral infections2022
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2021
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2021
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors2021